Search filters

List of works by Yusuf Yılmaz

"Defragmenting" the noninvasive diagnosis of nonalcoholic steatohepatitis: hopes from cytokeratin-18

scientific article published on 01 September 2009

A "biomarker biopsy" for the diagnosis of NASH: promises from CK-18 fragments

scientific article published on 5 August 2008

A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease

scientific article published in November 2014

Acute arsenic self-poisoning for suicidal purpose in a dentist: a case report

scientific article

Acute myocardial infarction, ischemic cerebrovascular disease and variceal bleeding due to portal vein thrombosis in a patient with hereditary thrombophilia

scientific article published in April 2008

Apoptosis in nonalcoholic steatohepatitis with normal aminotransferase values: zooming in on cytokeratin 18 fragments.

scientific article published on October 2010

Apoptosis: why and how does it occur in biology?

scientific article published on 19 July 2011

Assessment of endothelial function in patients with nonalcoholic fatty liver disease

scientific article published on 3 June 2012

Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans

scientific article published on 01 June 2011

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis

scientific article

Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity.

scientific article published in April 2009

Biomarkers for early detection of non-alcoholic steatohepatitis: implications for drug development and clinical trials.

scientific article published on October 2013

Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: tools or decorations?

scientific article published on September 2009

Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B

scientific article published on 31 August 2010

Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome

Cigarette smoking is not associated with specific histological features or severity of nonalcoholic fatty liver disease

scientific article published on 01 July 2010

Circulating levels of vascular endothelial growth factor A and its soluble receptor in patients with biopsy-proven nonalcoholic fatty liver disease

scientific article published on 01 January 2011

Circulating vaspin and its relationship with insulin sensitivity, adiponectin and liver histology in subjects with non-alcoholic steatohepatitis

scientific article published on December 19, 2011

Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease.

scientific article published on 29 March 2011

Clinical Value of the Malnutrition-Inflammation-Atherosclerosis Syndrome for Long-Term Prediction of Cardiovascular Mortality in Patients with End-Stage Renal Disease: A 5-Year Prospective Study

scientific article published on 22 January 2008

Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease

scientific article published on 02 January 2020

Commentary on "Cytokeratin 18, a Marker of Cell Death, is Increased in Children With Suspected Nonalcoholic Fatty Liver Disease"

scientific article published on 01 September 2009

Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients

scientific article published on 26 August 2009

Concentrations of connective tissue growth factor in patients with nonalcoholic fatty liver disease: association with liver fibrosis.

scientific article published on January 2012

Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis

scientific article published on 07 February 2010

Cytokeratins in hepatitis.

scientific article published on 08 September 2011

Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease

scientific article published on 13 February 2009

Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy

scientific article published on 11 March 2014

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

scientific article published in 2021

Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease

scientific article published on 7 June 2008

Effect of intensive statin therapy on arterial elasticity in patients with coronary artery disease

scientific article

Evaluation of leukocyte esterase and nitrite strip tests to detect spontaneous bacterial peritonitis in cirrhotic patients.

scientific article

Folic Acid and vitamin B12 supplementation improves coronary flow reserve in elderly subjects with vitamin B12 deficiency

scientific article published in July 2010

Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease

scientific article

Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease

scientific article published on 8 November 2012

Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in non-alcoholic fatty liver disease

scientific article published on 24 July 2019

Human serum complement C3 and factor H in the syndrome of hemolysis, elevated liver enzymes, and low platelet count

scientific article published on 24 August 2009

Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis

scientific article published on 17 August 2012

Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease.

scientific article published on 19 August 2010

Is M65 really better than M30 as a biomarker of hepatic fibrosis?

scientific article published on 01 February 2012

Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome?

scientific article published on December 2012

Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori

scientific article published on 27 December 2010

Letter: a stepwise approach towards the screening of hepatic fibrosis in the general population

scientific article published on 01 March 2020

Letter: diagnostic accuracy of M30 levels for identifying patients with non‐alcoholic steatohepatitis

scientific article published on 01 January 2013

Letter: gut microbiota modulation contributes to coffee's benefits for non-alcoholic fatty liver disease - authors' reply

scientific article published on 01 June 2014

Letter: the perilous road to a functional cure for hepatitis B infection

scientific article published on 01 March 2020

Letter: the use of Fibrosis-4 score in primary care and diabetology practices-Occam's razor applied to advanced fibrosis screening

scientific article published on 01 December 2020

Liver disease and malnutrition.

scientific article published on August 2013

Liver disease as a risk factor for cognitive decline and dementia: an under-recognized issue

scientific article published on 01 February 2009

Liver enzymes and cardiovascular outcomes: A new research agenda

scientific article published on June 30, 2010

Liver function tests: Association with cardiovascular outcomes

scientific article published on April 27, 2010

Metformin, hepatitis C, and insulin resistance: sufficient evidence?

scientific article published in December 2009

Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis

scientific article published on 22 January 2010

Molecular signatures of nonalcoholic fatty liver disease: the present and future

scientific article published on 01 May 2010

Multimarker strategies for detecting NASH and NASH-related fibrosis: promises and caveats

scientific article published on 01 August 2011

NAFLD in the absence of metabolic syndrome: different epidemiology, pathogenetic mechanisms, risk factors for disease progression?

scientific article published on February 2012

NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?

scientific article published on 09 July 2019

Non-alcoholic fatty liver disease and microalbuminuria in non-diabetic patients: role of insulin resistance

scientific article published on 01 October 2009

Nonalcoholic Fatty Liver Disease: A Nutritional Approach

scientific article published on 06 March 2012

Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography

scientific article published on 01 November 2013

Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease

scientific article published on 30 January 2014

Obesity-associated nonalcoholic fatty liver disease.

scientific article published on 24 October 2013

Plasma Fibrinogen-Like Protein 2 Levels in Patients with Non-Alcoholic Fatty Liver Disease

scientific article published on November 1, 2011

Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis

scientific article published in April 2010

Predictive value of the modified Early Warning Score in a Turkish emergency department

scientific article published on 01 December 2008

Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease

article

Preliminary evidence of an association between the functional c-kit rs6554199 polymorphism and achalasia in a Turkish population

scientific article published on 26 September 2011

Protective effect of the vasopressin agonist terlipressin in a rat model of contrast-induced nephropathy

scientific article published on 04 March 2011

Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry

scientific article

Psychopathology in the context of obesity: the adiponectin hypothesis

scientific article published on 24 October 2007

Research update for articles published in EJCI in 2010

Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease.

scientific article published on 11 September 2013

Review article: fructose in non‐alcoholic fatty liver disease

scientific article published on 02 April 2012

Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?

scientific article published on November 1, 2012

Review article: non-alcoholic fatty liver disease and osteoporosis--clinical and molecular crosstalk.

scientific article published on 26 June 2012

Serial changes in circulating M30 antigen, a biomarker of apoptosis, in patients with acute coronary syndromes: relationship with the severity of coronary artery disease

scientific article published on 01 December 2009

Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels

scientific article published in February 2009

Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance.

scientific article published in November 2009

Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology

scientific article published on 01 March 2012

Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis

scientific article published on 06 October 2010

Serum galectin-3 levels in patients with nonalcoholic fatty liver disease

scientific article published on 24 May 2011

Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis

scientific article published on 01 May 2009

Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease.

scientific article

Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease

scientific article published on 01 September 2010

Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease

scientific article published on 14 October 2010

Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity

scientific article published on April 15, 2011

Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease

scientific article published on 26 June 2010

Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration

scientific article published on 22 August 2011

Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease

scientific article

Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis

scientific article published on 24 August 2011

Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease

scientific article published on January 1, 2011

Serum proteomics for biomarker discovery in nonalcoholic fatty liver disease

scientific article published on April 23, 2012

Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease

scientific article published on 16 November 2010

Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease

scientific article published on 19 September 2019

Small arterial elasticity predicts the extent of coronary artery disease: Relationship with serum uric acid

scientific article published on 22 April 2008

Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease.

scientific article published on 21 September 2009

The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease

scientific article published in January 2008

The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease.

scientific article published on 27 May 2008

The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy

scientific article published on 07 April 2011

The quest for liver fibrosis biomarkers: promises from the enhanced liver fibrosis panel and beyond

scientific article published on 01 March 2009

Unconjugated hyperbilirubinemia and liver histology in patients with non-alcoholic fatty liver disease

scientific article published on 09 February 2012

Urinary IL-18: a marker of contrast-induced nephropathy following percutaneous coronary intervention?

scientific article published on 16 January 2008